Adverse Drug Reactions of Tyrosine Kinase Inhibitors in the Treatment of Advanced Lung Cancer

Journal Title: International Journal of Medical Research Professionals - Year 2018, Vol 4, Issue 5

Abstract

Introduction: Erlotinib and gefitinib are the most commonly used epidermal growth factor receptor‑tyrosine kinase inhibitors (EGFR‑TKIs) in the treatment of EGFR mutant nonsmall cell lung cancer (NSCLC). Both erlotinib and gefitinib have shown equal efficacy in terms of response rates and overall survival. Hence, their toxicity profile becomes the most important determining factor in choosing these agents when treating EGFR mutant NSCLC. In this study, we compared the toxicity profile of erlotinib and gefitinib among an Indian subset of lung cancer patients. Materials and Methods: In this prospective nonrandomized study, 85 patients came at Acharya Tulsi Regional Cancer Treatment & Research Institute with NSCLC were tested for EGFR mutation status, and EGFR mutant patients were started on either erlotinib or gefitinib. They were periodically monitored for drug toxicities. Results: Out of the 85 patients tested, 34 patients were positive for EGFR mutation. Eleven of them were started on erlotinib and 23 were started on gefitinib. The most common side effect of TKIs was skin rash. Nine out of the 11 patients started on erlotinib and 7 of the 23 patients started on gefitinib had skin rash. Grade 3 and 4 skin rash was significantly more among patients treated with erlotinib which resulted in treatment delays. Other side effects of TKIs such as diarrhea and deranged liver functions were similar among the both subsets of patients. Conclusion: Skin toxicity is the major and serious side effect with erlotinib among Indian patients with EGFR mutant lung cancer. This resulted in significant treatment delay, which might adversely affect the overall survival of patients. Gefitinib was better tolerated and had a safer toxicity profile compared to erlotinib in Indian patients.

Authors and Affiliations

Pankaj Tantia, Ritika Agarwal, Jitendra Acharya

Keywords

Related Articles

Demographic and Characteristic Distribution of End Stage Renal Failure in Sulaimani Governorate, Kurdistan Region, Iraq

Background: End stage renal Disease (ESRD) is a major health problem and is rapidly progressing among population worldwide. There are limited data about the prevalence of ESRD in Iraq in general and in Sulaimani governor...

Prevalence of Dental Fluorosis among Primary School Children in Rural Areas of Lucknow, Uttar Pradesh, India

In preventive dentistry fluoride plays an essential role due to its cariostatic potential. However, excessive intake of fluoride leads to dental and skeletal fluorosis. Millions of people in India suffer from dental, ske...

Impact of Teaching Communication Skills to Undergraduate Medical Students

Introduction: Effective communication between doctor and patient helps in improving compliance as well as decreases the risk of complications associated with the treatment. Therefore, medical students need to be trained...

Exposure to Violence among Physicians Working at the Primary Care in the Kingdom of Bahrain

Background: Violence against healthcare workers is a critical problem, regardless of its form. It has a range of physical and psychological outcomes, affecting their health and productivity. Published studies about the p...

Case of Filarial Pericardial Effusion Presented as Cardiac Tamponade in Medica Heart Institute, Patna, Bihar

Case of filarial pericardial effusion is reported for its rarity. Pericardial effusion is a common problem aetiolgy varies demanding meticulous clinical and laboratory work up. Parasitic infections are rare cause of peri...

Download PDF file
  • EP ID EP537146
  • DOI 10.21276/ijmrp.2018.4.5.064
  • Views 97
  • Downloads 0

How To Cite

Pankaj Tantia, Ritika Agarwal, Jitendra Acharya (2018). Adverse Drug Reactions of Tyrosine Kinase Inhibitors in the Treatment of Advanced Lung Cancer. International Journal of Medical Research Professionals, 4(5), 283-285. https://www.europub.co.uk/articles/-A-537146